Article

Essilor to acquire Satisloh

Essilor International has agreed to purchase Satisloh Holding AG, a leading supplier of prescription laboratory equipment.

Charenton-le-Pont, France, and Horgen, Switzerland-Essilor International has agreed to purchase Satisloh Holding AG, a leading supplier of prescription laboratory equipment. The acquisition is expected to close later this year, subject to certain conditions including approval by competition authorities in countries where Satisloh does business.

Satisloh manufactures antireflective coating units and surfacing machines, as well as consumables, and markets its products through its own global distribution network. Satisloh has more than 400 employees and reported 2007 revenues of 161 million (approximately US $250 million).

According to Essilor, the combined capabilities and expertise of Satisloh and Essilor will facilitate a broader, more competitive range of products and services, with shorter time-to-market cycles. The acquisition will not only open up a new area of business, but also will enable the development of services for labs, optical chains, and eye-care professionals around the world, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.